NIH #R01CA240638
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors
Expiring Soon
- Amount
- $400K–$500K
- Period
- 2021-04-01 → 2026-11-30
- PIs
- 3
Shivaani Kummar
Full Professor(heuristic)
Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index59
i10-index181
Publications650
Citations15,317
Grants
4 total · 3 active
NIH #T32CA285265
Experimental Therapeutics in Cancer Training Program
Active
- Amount
- $200K–$300K
- Period
- 2025-01-15 → 2029-12-31
- PIs
- 2
NIH #P30CA069533
OHSU Knight Cancer Institute
Active
- Amount
- $2M–$3M
- Period
- 1997-08-01 → 2027-06-30
- PIs
- 1
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Targeting of Wnt–β-Catenin Pathway in Recurrent Ameloblastoma (New England Journal of Medicine)2026-06-03
- New NIH award: Experimental Therapeutics in Cancer Training Program2025-01-15
- New NIH award: [18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors2021-04-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0001-6906-1627